Pituitary

Article	Citations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	73
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	44
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	39
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	37
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	32
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	32
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	29
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	29
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	26
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	24
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	23
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	23
Pituitary: hic manebimus optime	23
Genetic models of Cushing’s disease	23
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	22
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	21
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	21
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	21
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	21
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	19
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	19
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	19
Machine learning as a clinical decision support tool for patients with acromegaly	18
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	18
Pituitary metastases: a case series and scoping review	18

The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	18
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	18
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	18
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	17
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	16
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	16
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	16
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	16
IGF-1 is positively associated with BMI in patients with acromegaly	15
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	15
TSH-secreting pituitary adenomas and bone	15
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	15
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	15
Cushing’s disease and bone	15
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	14
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	14
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	14
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	14
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	13
Acromegaly is associated with a distinct oral and gut microbiota	13
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	13
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	13
Copeptin after pituitary surgery: is it worth measuring?	13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	13
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	12
Is diabetes with acromegaly for life?	12
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	12
Pituitary surgery and COVID	12
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	11
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	11
Mental health disorders in newly diagnosed non-functional pitutary adenoma under initial observation: an observational cohort study using the nationwide MarketScan database	11
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	11
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	11
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	11
Long COVID and pituitary dysfunctions: a bidirectional relationship?	11
Refractory nonfunctioning pituitary adenomas	10
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	10
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	10
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	10
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	10
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	10
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	10
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	10
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	10
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	10
An update on, and genetics of refractory adenomas of childhood	9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	9

High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	9
Skeletal fragility in pituitary disease: how can we predict fracture risk?	9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	9
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	9
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	9
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	9
Cushing’s disease: role of preoperative and primary medical therapy	9
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	8
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	8
Cushing’s syndrome: Guidance on thromboprophylaxis at last	8
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	8
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	8
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	8
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	8
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	8
Correction: consensus on criteria for acromegaly diagnosis and remission	8
How to manage intolerance to dopamine agonist in patients with prolactinoma	8
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	8
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	7
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre	7
Pituitary acting drugs: cabergoline and pasireotide	7
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	7
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma	7
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	7
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	7
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	7
Elevated risk of recurrence and retreatment for silent pituitary adenomas	7
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	7
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	7
Metastases to the pituitary gland: insights from the German pituitary tumor registry	7
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center	7
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center	6
Cushing’s disease in children: unique features and update on genetics	6
Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent manners	6
Letter to the editor regarding “Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature”	6
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	6
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis	6
Cushing’s syndrome and COVID-19	6
Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications	6
Posterior pituitary tumors: an entity unto itself	6
Role of Radiation in the treatment of Cushing Disease	6
Novel imaging techniques in refractory pituitary adenomas	6
GHR disruption in mature adult mice alters xenobiotic metabolism gene expression in the liver	6
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus	6
Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice	6
Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity	6
Vitamin D in pituitary driven osteopathies	6
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	6
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	5
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	5
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	5
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	5
Sheehan syndrome: a current approach to a dormant disease	5
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	5
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?	5
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas	5
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	5
A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	5
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay	5
Changing the name of diabetes insipidus	5
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	5
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	5
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	5
Cushing’s disease: adrenal steroidogenesis inhibitors	5
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	4
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	4
Opioids and pituitary function: expert opinion	4
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	4
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	4
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	4
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	4
Hypopituitarism and COVID-19	4

A prospective study on the efficacy of oral estrogen in female patients with acromegaly	4
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	4
Precocious puberty, pandemic and beyond	4
Kidney function in acromegaly: evidence from a long-term observational study	4
Correlates of prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenomas: varying definitions and non-clinical factors	3
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there?	3
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing’s disease: safety, feasibility, and success	3
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	3
Epigenetic implications in the pathogenesis of corticotroph tumors	3
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	3
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	3
FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours	3
Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases	3
Advances in surgical approaches for refractory pituitary adenomas	3
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	3
A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system	3
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	3
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	3
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	3
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI	3
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	3
Enhancing diagnostic tools for vasopressin deficiency: insights from a single-center cohort study	3
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis	3
Impact of insurance on outcomes of patients undergoing endoscopic transsphenoidal surgery for non-functional pituitary adenomas: a single institution study	3
Impact of nasal septal deviation on surgical outcomes in endoscopic transsphenoidal surgery: a population-based study	3
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review	3
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	3
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society	3
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	3
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	3
Pituitary and COVID-19 vaccination: a systematic review	2
Pituitary apoplexy score, toward standardized decision-making: a descriptive study	2
Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts	2
Frailty and pituitary surgery: a systematic review	2
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2	2
Delayed postoperative hyponatremia in patients with acromegaly: incidence and predictive factors	2
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview	2
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	2
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)	2
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas	2
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery	2
Cushing’s disease: role of bilateral adrenalectomy	2
Newer parameters of the octreotide test in patients with acromegaly	2
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile	2
Prolactin immunoassay: does the high-dose hook effect still exist?	2
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas	2
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers	2
Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series	2
Treatment of acromegaly-induced diabetes: an updated proposal	2
Lateral orientation of Rathke cleft cysts may be associated with high rates of recurrence after surgery	2
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation	2
Typing of inflammatory lesions of the pituitary	2
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients	2
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study	2
Colonoscopy in acromegaly: when and why	2
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study	2
Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades	2
Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis	2
Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency	2
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events	2
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	2
Surgical outcomes and quality of life in Rathke’s cleft cysts undergoing endoscopic transsphenoidal resection: a multicentre study and systematic review of the literature	2
Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas	2
Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study	2